Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Journal of thrombosis and haemostasis : JTH·2018
Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
Journal of thrombosis and haemostasis : JTH·2016
Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
Journal of thrombosis and haemostasis : JTH·2015
Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry.
Journal of thrombosis and haemostasis : JTH·2015
Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.
Journal of thrombosis and haemostasis : JTH·2013
Impella 5.5 as a bridge to dual-organ transplantation.
The International journal of artificial organs·2026